APO Research
Talk to an analyst

APO RESEARCH · REPORT

Atezolizumab

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Atezolizumab Industry Growth and Trends Forecast to 2032

23 December 202574 pages

Choose your research edition.

Industry ResearchAtezolizumab Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Atezolizumab Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Atezolizumab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Atezolizumab Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Atezolizumab Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Atezolizumab market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Atezolizumab is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Atezolizumab is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Atezolizumab is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Atezolizumab include Genentech (Roche). among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Atezolizumab market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Atezolizumab market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Atezolizumab market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Atezolizumab.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Atezolizumab market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Atezolizumab Market by Company

Genentech (Roche)

Atezolizumab Segment by Type

Use: Single Drug

Use: ChemOthersapy Combination

Atezolizumab Segment by Application

Advanced Triple-negative Breast Cancer

Head and Neck Cancer

Renal Cell Carcinoma

Urothelial Carcinoma

Hepatocellular Carcinoma (HCC)

Lung Cancer

Bladder Cancer

Others

Atezolizumab Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atezolizumab market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Atezolizumab and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atezolizumab.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Atezolizumab manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Atezolizumab in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Use: Single Drug Table 2. Major Company of Use: ChemOthersapy Combination Table 3. Global Atezolizumab Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Atezolizumab Sales by Type (2021-2026) & (k units) Table 5. Global Atezolizumab Sales Market Share in Volume by Type (2021-2026) Table 6. Global Atezolizumab Sales by Type (2021-2026) & (US$ Million) Table 7. Global Atezolizumab Sales Market Share in Value by Type (2021-2026) Table 8. Global Atezolizumab Price by Type (2021-2026) & (US$/unit) Table 9. Global Atezolizumab Sales by Type (2027-2032) & (k units) Table 10. Global Atezolizumab Sales Market Share in Volume by Type (2027-2032) Table 11. Global Atezolizumab Sales by Type (2027-2032) & (US$ Million) Table 12. Global Atezolizumab Sales Market Share in Value by Type (2027-2032) Table 13. Global Atezolizumab Price by Type (2027-2032) & (US$/unit) Table 14. North America Atezolizumab Sales by Type (2021-2026) & (k units) Table 15. North America Atezolizumab Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Atezolizumab Sales by Type (2021-2026) & (k units) Table 17. Europe Atezolizumab Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Atezolizumab Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Atezolizumab Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Atezolizumab Sales by Type (2021-2026) & (k units) Table 21. Latin America Atezolizumab Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Atezolizumab Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Atezolizumab Sales by Type (2021-2026) & (US$ Million) Table 24. Atezolizumab Industry Trends Table 25. Atezolizumab Industry Drivers Table 26. Atezolizumab Industry Opportunities and Challenges Table 27. Atezolizumab Industry Restraints Table 28. Global Atezolizumab Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Atezolizumab Revenue Market Share by Company (2021-2026) Table 30. Global Atezolizumab Sales by Company (2021-2026) & (k units) Table 31. Global Atezolizumab Sales Share by Company (2021-2026) Table 32. Global Atezolizumab Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Atezolizumab Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Atezolizumab Major Company Production Sites and Headquarters Table 35. Global Atezolizumab Company, Product Type & Application Table 36. Global Atezolizumab Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Atezolizumab by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Atezolizumab Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Atezolizumab Sales by Region (2021-2026) & (k units) Table 41. Global Atezolizumab Sales Market Share in Volume by Region (2021-2026) Table 42. Global Atezolizumab Sales by Region (2021-2026) & (US$ Million) Table 43. Global Atezolizumab Sales Market Share in Value by Region (2021-2026) Table 44. Global Atezolizumab Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Atezolizumab Sales by Region (2027-2032) & (k units) Table 46. Global Atezolizumab Sales Market Share in Volume by Region (2027-2032) Table 47. Global Atezolizumab Sales by Region (2027-2032) & (US$ Million) Table 48. Global Atezolizumab Sales Market Share in Value by Region (2027-2032) Table 49. Global Atezolizumab Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Atezolizumab Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Atezolizumab Sales by Application (2021-2026) & (k units) Table 52. Global Atezolizumab Sales Market Share in Volume by Application (2021-2026) Table 53. Global Atezolizumab Sales by Application (2021-2026) & (US$ Million) Table 54. Global Atezolizumab Sales Market Share in Value by Application (2021-2026) Table 55. Global Atezolizumab Price by Application (2021-2026) & (US$/unit) Table 56. Global Atezolizumab Sales by Application (2027-2032) & (k units) Table 57. Global Atezolizumab Sales Market Share in Volume by Application (2027-2032) Table 58. Global Atezolizumab Sales by Application (2027-2032) & (US$ Million) Table 59. Global Atezolizumab Sales Market Share in Value by Application (2027-2032) Table 60. Global Atezolizumab Price by Application (2027-2032) & (US$/unit) Table 61. North America Atezolizumab Sales by Application (2021-2026) & (k units) Table 62. North America Atezolizumab Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Atezolizumab Sales by Application (2021-2026) & (k units) Table 64. Europe Atezolizumab Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Atezolizumab Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Atezolizumab Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Atezolizumab Sales by Application (2021-2026) & (k units) Table 68. Latin America Atezolizumab Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Atezolizumab Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Atezolizumab Sales by Application (2021-2026) & (US$ Million) Table 71. Genentech (Roche) Company Information Table 72. Genentech (Roche) Business Overview Table 73. Genentech (Roche) Atezolizumab Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Genentech (Roche) Atezolizumab Product Portfolio Table 75. Genentech (Roche) Recent Development Table 76. North America Atezolizumab Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 77. North America Atezolizumab Sales by Country (2021-2026) & (k units) Table 78. North America Atezolizumab Sales Market Share by Country (2021-2026) Table 79. North America Atezolizumab Sales Forecast by Country (2027-2032) & (k units) Table 80. North America Atezolizumab Sales Market Share Forecast by Country (2027-2032) Table 81. North America Atezolizumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 82. North America Atezolizumab Market Size by Country (2021-2026) & (US$ Million) Table 83. North America Atezolizumab Market Share by Country (2021-2026) Table 84. North America Atezolizumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 85. North America Atezolizumab Market Share Forecast by Country (2027-2032) Table 86. Europe Atezolizumab Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 87. Europe Atezolizumab Sales by Country (2021-2026) & (k units) Table 88. Europe Atezolizumab Sales Market Share by Country (2021-2026) Table 89. Europe Atezolizumab Sales Forecast by Country (2027-2032) & (k units) Table 90. Europe Atezolizumab Sales Market Share Forecast by Country (2027-2032) Table 91. Europe Atezolizumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. Europe Atezolizumab Market Size by Country (2021-2026) & (US$ Million) Table 93. Europe Atezolizumab Market Share by Country (2021-2026) Table 94. Europe Atezolizumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. Europe Atezolizumab Market Share Forecast by Country (2027-2032) Table 96. Asia-Pacific Atezolizumab Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 97. Asia-Pacific Atezolizumab Sales by Country (2021-2026) & (k units) Table 98. Asia-Pacific Atezolizumab Sales Market Share by Country (2021-2026) Table 99. Asia-Pacific Atezolizumab Sales Forecast by Country (2027-2032) & (k units) Table 100. Asia-Pacific Atezolizumab Sales Market Share Forecast by Country (2027-2032) Table 101. Asia-Pacific Atezolizumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Asia-Pacific Atezolizumab Market Size by Country (2021-2026) & (US$ Million) Table 103. Asia-Pacific Atezolizumab Market Share by Country (2021-2026) Table 104. Asia-Pacific Atezolizumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Asia-Pacific Atezolizumab Market Share Forecast by Country (2027-2032) Table 106. Latin America Atezolizumab Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. Latin America Atezolizumab Sales by Country (2021-2026) & (k units) Table 108. Latin America Atezolizumab Sales Market Share by Country (2021-2026) Table 109. Latin America Atezolizumab Sales Forecast by Country (2027-2032) & (k units) Table 110. Latin America Atezolizumab Sales Market Share Forecast by Country (2027-2032) Table 111. Latin America Atezolizumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Latin America Atezolizumab Market Size by Country (2021-2026) & (US$ Million) Table 113. Latin America Atezolizumab Market Share by Country (2021-2026) Table 114. Latin America Atezolizumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Latin America Atezolizumab Market Share Forecast by Country (2027-2032) Table 116. Middle East and Africa Atezolizumab Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Middle East and Africa Atezolizumab Sales by Country (2021-2026) & (k units) Table 118. Middle East and Africa Atezolizumab Sales Market Share by Country (2021-2026) Table 119. Middle East and Africa Atezolizumab Sales Forecast by Country (2027-2032) & (k units) Table 120. Middle East and Africa Atezolizumab Sales Market Share Forecast by Country (2027-2032) Table 121. Middle East and Africa Atezolizumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Middle East and Africa Atezolizumab Market Size by Country (2021-2026) & (US$ Million) Table 123. Middle East and Africa Atezolizumab Market Share by Country (2021-2026) Table 124. Middle East and Africa Atezolizumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Middle East and Africa Atezolizumab Market Share Forecast by Country (2027-2032) Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. Atezolizumab Distributors List Table 129. Atezolizumab Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Atezolizumab Image Figure 2. Global Atezolizumab Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Atezolizumab Market Size (2021-2032) & (US$ Million) Figure 4. Global Atezolizumab Sales (2021-2032) & (k units) Figure 5. Use: Single Drug Image Figure 6. Global Use: Single Drug Sales YoY Growth (2021-2032) & (k units) Figure 7. Use: ChemOthersapy Combination Image Figure 8. Global Use: ChemOthersapy Combination Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Atezolizumab Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Atezolizumab Market Share by Type 2025 VS 2032 Figure 11. North America Atezolizumab Sales Market Share in Volume by Type in 2025 Figure 12. North America Atezolizumab Sales Market Share in Value by Type in 2025 Figure 13. Europe Atezolizumab Sales Market Share in Volume by Type in 2025 Figure 14. Europe Atezolizumab Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Atezolizumab Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Atezolizumab Sales Market Share in Value by Type in 2025 Figure 17. Latin America Atezolizumab Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Atezolizumab Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Atezolizumab Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Atezolizumab Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Atezolizumab Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Advanced Triple-negative Breast Cancer Image Figure 24. Global Advanced Triple-negative Breast Cancer Sales YoY Growth (2021-2032) & (k units) Figure 25. Head and Neck Cancer Image Figure 26. Global Head and Neck Cancer Sales YoY Growth (2021-2032) & (k units) Figure 27. Renal Cell Carcinoma Image Figure 28. Global Renal Cell Carcinoma Sales YoY Growth (2021-2032) & (k units) Figure 29. Urothelial Carcinoma Image Figure 30. Global Urothelial Carcinoma Sales YoY Growth (2021-2032) & (k units) Figure 31. Hepatocellular Carcinoma (HCC) Image Figure 32. Global Hepatocellular Carcinoma (HCC) Sales YoY Growth (2021-2032) & (k units) Figure 33. Lung Cancer Image Figure 34. Global Lung Cancer Sales YoY Growth (2021-2032) & (k units) Figure 35. Bladder Cancer Image Figure 36. Global Bladder Cancer Sales YoY Growth (2021-2032) & (k units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 39. Global Atezolizumab Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Atezolizumab Market Share by Application 2025 VS 2032 Figure 41. North America Atezolizumab Sales Market Share in Volume by Application in 2025 Figure 42. North America Atezolizumab Sales Market Share in Value by Application in 2025 Figure 43. Europe Atezolizumab Sales Market Share in Volume by Application in 2025 Figure 44. Europe Atezolizumab Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Atezolizumab Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Atezolizumab Sales Market Share in Value by Application in 2025 Figure 47. Latin America Atezolizumab Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Atezolizumab Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Atezolizumab Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Atezolizumab Sales Market Share in Value by Application in 2025 Figure 51. North America Atezolizumab Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. North America Atezolizumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Atezolizumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Atezolizumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Atezolizumab Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Europe Atezolizumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Atezolizumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Atezolizumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Atezolizumab Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Asia-Pacific Atezolizumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Atezolizumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Atezolizumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Atezolizumab Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Latin America Atezolizumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Atezolizumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Atezolizumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Atezolizumab Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 68. Middle East and Africa Atezolizumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Atezolizumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Atezolizumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Atezolizumab Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Atezolizumab Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Use: Single Drug
  • Use: ChemOthersapy Combination
Applications
  • Advanced Triple-negative Breast Cancer
  • Head and Neck Cancer
  • Renal Cell Carcinoma
  • Urothelial Carcinoma
  • Hepatocellular Carcinoma (HCC)
  • Lung Cancer
  • Bladder Cancer
  • Others
Companies covered
  • Genentech (Roche)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Atezolizumab Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Atezolizumab Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Atezolizumab Market by Type
  6. 1.3.1 Use: Single Drug
  7. 1.3.2 Use: ChemOthersapy Combination
  8. 1.4 Global Atezolizumab Market Size by Type
  9. 1.4.1 Global Atezolizumab Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Atezolizumab Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Atezolizumab Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Atezolizumab Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Atezolizumab Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Atezolizumab Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Atezolizumab Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Atezolizumab Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Atezolizumab Industry Trends
  2. 2.2 Atezolizumab Industry Drivers
  3. 2.3 Atezolizumab Industry Opportunities and Challenges
  4. 2.4 Atezolizumab Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Atezolizumab Revenue (2021-2026)
  2. 3.2 Global Top Players by Atezolizumab Sales (2021-2026)
  3. 3.3 Global Top Players by Atezolizumab Price (2021-2026)
  4. 3.4 Global Atezolizumab Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Atezolizumab Major Company Production Sites & Headquarters
  6. 3.6 Global Atezolizumab Company, Product Type & Application
  7. 3.7 Global Atezolizumab Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Atezolizumab Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Atezolizumab Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Atezolizumab Tier 1, Tier 2, and Tier 3
4 Atezolizumab Regional Status and Outlook
  1. 4.1 Global Atezolizumab Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Atezolizumab Historic Market Size by Region
  3. 4.2.1 Global Atezolizumab Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Atezolizumab Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Atezolizumab Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Atezolizumab Forecasted Market Size by Region
  7. 4.3.1 Global Atezolizumab Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Atezolizumab Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Atezolizumab Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Atezolizumab by Application
  1. 5.1 Atezolizumab Market by Application
  2. 5.1.1 Advanced Triple-negative Breast Cancer
  3. 5.1.2 Head and Neck Cancer
  4. 5.1.3 Renal Cell Carcinoma
  5. 5.1.4 Urothelial Carcinoma
  6. 5.1.5 Hepatocellular Carcinoma (HCC)
  7. 5.1.6 Lung Cancer
  8. 5.1.7 Bladder Cancer
  9. 5.1.8 Others
  10. 5.2 Global Atezolizumab Market Size by Application
  11. 5.2.1 Global Atezolizumab Market Size Overview by Application (2021-2032)
  12. 5.2.2 Global Atezolizumab Historic Market Size Review by Application (2021-2026)
  13. 5.2.3 Global Atezolizumab Forecasted Market Size by Application (2027-2032)
  14. 5.3 Key Regions Market Size by Application
  15. 5.3.1 North America Atezolizumab Sales Breakdown by Application (2021-2026)
  16. 5.3.2 Europe Atezolizumab Sales Breakdown by Application (2021-2026)
  17. 5.3.3 Asia-Pacific Atezolizumab Sales Breakdown by Application (2021-2026)
  18. 5.3.4 South America Atezolizumab Sales Breakdown by Application (2021-2026)
  19. 5.3.5 Middle East and Africa Atezolizumab Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Genentech (Roche)
  2. 6.1.1 Genentech (Roche) Company Information
  3. 6.1.2 Genentech (Roche) Business Overview
  4. 6.1.3 Genentech (Roche) Atezolizumab Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Genentech (Roche) Atezolizumab Product Portfolio
  6. 6.1.5 Genentech (Roche) Recent Developments
7 North America by Country
  1. 7.1 North America Atezolizumab Sales by Country
  2. 7.1.1 North America Atezolizumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Atezolizumab Sales by Country (2021-2026)
  4. 7.1.3 North America Atezolizumab Sales Forecast by Country (2027-2032)
  5. 7.2 North America Atezolizumab Market Size by Country
  6. 7.2.1 North America Atezolizumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Atezolizumab Market Size by Country (2021-2026)
  8. 7.2.3 North America Atezolizumab Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Atezolizumab Sales by Country
  2. 8.1.1 Europe Atezolizumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Atezolizumab Sales by Country (2021-2026)
  4. 8.1.3 Europe Atezolizumab Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Atezolizumab Market Size by Country
  6. 8.2.1 Europe Atezolizumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Atezolizumab Market Size by Country (2021-2026)
  8. 8.2.3 Europe Atezolizumab Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Atezolizumab Sales by Country
  2. 9.1.1 Asia-Pacific Atezolizumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Atezolizumab Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Atezolizumab Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Atezolizumab Market Size by Country
  6. 9.2.1 Asia-Pacific Atezolizumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Atezolizumab Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Atezolizumab Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Atezolizumab Sales by Country
  2. 10.1.1 South America Atezolizumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Atezolizumab Sales by Country (2021-2026)
  4. 10.1.3 South America Atezolizumab Sales Forecast by Country (2027-2032)
  5. 10.2 South America Atezolizumab Market Size by Country
  6. 10.2.1 South America Atezolizumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Atezolizumab Market Size by Country (2021-2026)
  8. 10.2.3 South America Atezolizumab Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Atezolizumab Sales by Country
  2. 11.1.1 Middle East and Africa Atezolizumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Atezolizumab Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Atezolizumab Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Atezolizumab Market Size by Country
  6. 11.2.1 Middle East and Africa Atezolizumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Atezolizumab Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Atezolizumab Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Atezolizumab Value Chain Analysis
  2. 12.1.1 Atezolizumab Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Atezolizumab Production Mode & Process
  7. 12.2 Atezolizumab Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Atezolizumab Distributors
  10. 12.2.3 Atezolizumab Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst